Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Neuroscience (ANRO) Capital Expenditures (2023 - 2026)

Alto Neuroscience has reported Capital Expenditures over the past 4 years, most recently at $941000.0 for Q1 2026.

  • Quarterly results put Capital Expenditures at $941000.0 for Q1 2026, up 3820.83% from a year ago — trailing twelve months through Mar 2026 was $941000.0 (down 49.81% YoY), and the annual figure for FY2025 was $24000.0, down 98.84%.
  • Capital Expenditures reached $941000.0 in Q1 2026 per ANRO's latest filing, up from $24000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $1.0 million in Q3 2024 and bottomed at -$75000.0 in Q3 2023.
  • Median Capital Expenditures over the past 4 years was $282000.0 (2024), compared with a mean of $351000.0.
  • The largest annual shift saw Capital Expenditures plummeted 89.29% in 2025 before it soared 3820.83% in 2026.
  • Over 4 years, Capital Expenditures stood at $470000.0 in 2023, then increased by 7.66% to $506000.0 in 2024, then crashed by 95.26% to $24000.0 in 2025, then skyrocketed by 3820.83% to $941000.0 in 2026.
  • Business Quant data shows Capital Expenditures for ANRO at $941000.0 in Q1 2026, $24000.0 in Q1 2025, and $506000.0 in Q4 2024.